NYSE - Delayed Quote ? USD Paragon 28, Inc. (FNA) Follow Compare 4.8900 +0.1100 (+2.30%) At close: October 25 at 4:00 PM EDT 4.8900 0.00 (0.00%) After hours: October 25 at 4:06 PM EDT All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations DexCom (DXCM) Surpasses Q3 Earnings and Revenue Estimates DexCom (DXCM) delivered earnings and revenue surprises of 4.65% and 0.27%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? yesterday DXCM FNA +2.30% Paragon 28 To Report Third Quarter 2024 Financial Results on November 12, 2024 ENGLEWOOD, Colo., October 17, 2024--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the third quarter 2024 after market close on Tuesday, November 12, 2024. The Company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time. Business Wire ? 8 days ago FNA +2.30% Paragon 28's Shares Rise After Launch of Phantom Fibula Nail System FNA unveils Phantom Fibula Nail System, a less invasive, next-gen solution for ankle fractures, offering enhanced precision, stability and better patient outcomes. Zacks ? 8 days ago FNA +2.30% ADUS DGX Paragon 28 Launches the Phantom? Fibula Nail System for Less Invasive Fracture Repair ENGLEWOOD, Colo., October 16, 2024--Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of the Phantom? Fibula Nail System, designed to give surgeons a less invasive option to treat the fibula when patients sustain an ankle fracture. Use of a fibula nail for the treatment of ankle fractures has been shown to have significantly fewer soft tissue complications, implant removals, and fracture nonunion when compared to plate and screw fixation, a common alternative approach.1 Business Wire ? 9 days ago FNA +2.30% Paragon 28 Inc (FNA) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... Despite impressive global revenue growth, Paragon 28 Inc (FNA) faces internal control issues and narrows its 2024 guidance amidst macroeconomic concerns. GuruFocus.com ? 16 days ago FNA +2.30% Paragon 28 Stock Gains From the Latest Launch of Its Right-Angle Drill FNA launched the Right-Angle Drill to enhance the APEX 3D Total Ankle Replacement System. The drill is designed to improve tibia preparation. Zacks ? last month FNA +2.30% Paragon 28 launches new ‘Right-Angle Drill’ for ankle replacements The new offering aims to enhance tibia preparation in ankle replacements. Medical Device Network ? last month FNA +2.30% Paragon 28 Introduces a Novel Right-Angle Drill for the APEX 3D? Total Ankle Replacement System ENGLEWOOD, Colo., September 10, 2024--Paragon 28, Inc. (NYSE: FNA) is pleased to announce the addition of a novel Right-Angle Drill to the APEX 3D? Total Ankle Replacement System designed to improve tibia preparation prior to the implantation of the APEX 3D? tibia implant. The Right-Angle Drill utilizes a linear guide to precisely drill vertical holes into the tibia for ideal peg placement and a highly stable tibia implant interface. Business Wire ? last month FNA +2.30% Will Paragon 28 Stock Gain From the Latest Product Launch of R3FLEX? FNA recently introduced the R3FLEX Stabilization System, whose design should allow surgeons to restore a patient's soft tissue to a more natural anatomy. Zacks ? last month FNA +2.30% Paragon 28 introduces R3FLEX stabilisation system for ankle syndesmosis The system offers surgeons the ability to adjust and visualise tension accurately during the repair process. Medical Device Network ? last month FNA +2.30% Paragon 28 Launches the R3FLEX? Stabilization System to Anatomically Repair Ankle Syndesmotic Injuries ENGLEWOOD, Colo., September 04, 2024--Paragon 28, Inc. (NYSE: FNA), is pleased to announce the launch of the R3FLEX? Stabilization System, which is designed to restore stability to the ankle syndesmosis after injury from an ankle fracture or high ankle sprain. Business Wire ? last month FNA +2.30% Paragon 28 (FNA) Expands SMART 28 Ecosystem With New Launches Paragon 28 (FNA) strengthens its position in the foot and ankle device market with the launch of the SMART28 Case Management Portal and the SMART Bun-Yo-Matic device. Zacks ? 2 months ago FNA +2.30% DGX Paragon 28 Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line Paragon 28 ( NYSE:FNA ) Second Quarter 2024 Results Key Financial Results Revenue: US$61.0m (up 20% from 2Q 2023). Net... Simply Wall St. ? 2 months ago FNA +2.30% Paragon 28 Announces the Launch of SMART 28? Portal and First Case Using SMART Bun-Yo-Matic? ENGLEWOOD, Colo., August 14, 2024--Paragon 28, Inc. (NYSE: FNA), is proud to announce the launch of the SMART28? Case Management Portal, a cutting-edge platform that leverages AI and a seamless user experience to coordinate patient-specific surgical plans. It is the first major launch of Paragon 28’s SMART28? ecosystem, a portfolio of solutions and products that drive Paragon 28’s SMART28? initiative: to improve all aspects of foot and ankle treatments through the utilization of artificial intel Business Wire ? 2 months ago FNA +2.30% Analysts Have Been Trimming Their Paragon 28, Inc. (NYSE:FNA) Price Target After Its Latest Report There's been a notable change in appetite for Paragon 28, Inc. ( NYSE:FNA ) shares in the week since its quarterly... Simply Wall St. ? 2 months ago FNA +2.30% Paragon 28 Appoints Chadi Chahine as Chief Financial Officer and Executive Vice-President of Supply Chain Operations, Reports Second Quarter 2024 Financial Results and Narrows 2024 Net Revenue Guidance ENGLEWOOD, Colo., August 08, 2024--Paragon 28, Inc. (NYSE: FNA) ("Paragon 28" or "Company"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Chadi Chahine has been appointed Chief Financial Officer and Executive Vice-President of Supply Chain Operations, effective August 5, 2024. The Company also reported financial results for the quarter ended June 30, 2024, and narrowed its 2024 net revenue guidance. Business Wire ? 2 months ago FNA +2.30% Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates Nevro (NVRO) delivered earnings and revenue surprises of 31.75% and 2.76%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Zacks ? 2 months ago NVRO FNA +2.30% This Paragon 28 Insider Increased Their Holding In The Last Year Viewing insider transactions for Paragon 28, Inc.'s ( NYSE:FNA ) over the last year, we see that insiders were net... Simply Wall St. ? 2 months ago FNA +2.30% Paragon 28 to Report Second Quarter 2024 Financial Results on August 8, 2024 ENGLEWOOD, Colo., July 17, 2024--Paragon 28, Inc. (NYSE: FNA) ("PARAGON"), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2024 after market close on Thursday, August 8, 2024. The Company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time / 2:30 p.m. Mountain Time. Business Wire ? 3 months ago FNA +2.30% Paragon 28, Inc. (NYSE:FNA) Q1 2024 Earnings Call Transcript Paragon 28, Inc. (NYSE:FNA) Q1 2024 Earnings Call Transcript May 11, 2024 Paragon 28, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. And welcome to Paragon 28’s First Quarter 2024 Earnings Conference Call. Currently, participants are in […] Insider Monkey ? 5 months ago FNA +2.30% Performance Overview Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return FNA S&P 500 YTD -60.66% +21.77% 1-Year -45.36% +36.74% 3-Year -72.54% +27.79%
